144 related articles for article (PubMed ID: 17689566)
1. Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells.
Liou HH; Hsu HJ; Tsai YF; Shih CY; Chang YC; Lin CJ
Life Sci; 2007 Aug; 81(8):664-72. PubMed ID: 17689566
[TBL] [Abstract][Full Text] [Related]
2. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
3. Inhibition by dizocilpine (MK-801) of striatal dopamine release induced by MPTP and MPP+: possible action at the dopamine transporter.
Clarke PB; Reuben M
Br J Pharmacol; 1995 Jan; 114(2):315-22. PubMed ID: 7881731
[TBL] [Abstract][Full Text] [Related]
4. Acetyl-L-carnitine prevents total body hydroxyl free radical and uric acid production induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the rat.
Loots DT; Mienie LJ; Bergh JJ; Van der Schyf CJ
Life Sci; 2004 Jul; 75(10):1243-53. PubMed ID: 15219812
[TBL] [Abstract][Full Text] [Related]
5. Melatonin protects against MPTP/MPP+ -induced mitochondrial DNA oxidative damage in vivo and in vitro.
Chen LJ; Gao YQ; Li XJ; Shen DH; Sun FY
J Pineal Res; 2005 Aug; 39(1):34-42. PubMed ID: 15978055
[TBL] [Abstract][Full Text] [Related]
6. Differences in the disposition and toxicity of 1-methyl-4-phenylpyridinium in cultured rat and mouse astrocytes.
Tsai MJ; Lee EH
Glia; 1994 Dec; 12(4):329-35. PubMed ID: 7890335
[TBL] [Abstract][Full Text] [Related]
7. Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
Matarredona ER; Santiago M; Machado A; Cano J
Br J Pharmacol; 1997 Jul; 121(5):1038-44. PubMed ID: 9222565
[TBL] [Abstract][Full Text] [Related]
8. Inward transport of 3H-MPP+ in freshly isolated rat hepatocytes: evidence for interaction with catecholamines.
Martel F; Martins MJ; Azevedo I
Naunyn Schmiedebergs Arch Pharmacol; 1996; 354(3):305-11. PubMed ID: 8878060
[TBL] [Abstract][Full Text] [Related]
9. Neuroadaptive changes in the mesoaccumbens dopamine system after chronic nicotine self-administration: a microdialysis study.
Rahman S; Zhang J; Engleman EA; Corrigall WA
Neuroscience; 2004; 129(2):415-24. PubMed ID: 15501598
[TBL] [Abstract][Full Text] [Related]
10. Neurotoxicity studies with the monoamine oxidase B substrate 1-methyl-3-phenyl-3-pyrroline.
Ogunrombi MO; Malan SF; Terre'Blanche G; Castagnoli K; Castagnoli N; Bergh JJ; Petzer JP
Life Sci; 2007 Jul; 81(6):458-67. PubMed ID: 17655878
[TBL] [Abstract][Full Text] [Related]
11. Regulation of [(3)H]MPP(+) transport by phosphorylation/dephosphorylation pathways in RBE4 cells: role of ecto-alkaline phosphatase.
Calhau C; Martel F; Soares-da-Silva P; Hipólito-Reis C; Azevedo I
Naunyn Schmiedebergs Arch Pharmacol; 2002 May; 365(5):349-56. PubMed ID: 12012020
[TBL] [Abstract][Full Text] [Related]
12. Effect of dopaminergic neurotoxin MPTP/MPP+ on coenzyme Q content.
Dhanasekaran M; Karuppagounder SS; Uthayathas S; Wold LE; Parameshwaran K; Jayachandra Babu R; Suppiramaniam V; Brown-Borg H
Life Sci; 2008 Jul; 83(3-4):92-5. PubMed ID: 18565546
[TBL] [Abstract][Full Text] [Related]
13. MPP(+)-like neurotoxicity of a pyridinium metabolite derived from haloperidol: in vivo microdialysis and in vitro mitochondrial studies.
Rollema H; Skolnik M; D'Engelbronner J; Igarashi K; Usuki E; Castagnoli N
J Pharmacol Exp Ther; 1994 Jan; 268(1):380-7. PubMed ID: 8301579
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.
Wu KC; Lu YH; Peng YH; Tsai TF; Kao YH; Yang HT; Lin CJ
J Cereb Blood Flow Metab; 2015 Jan; 35(1):37-47. PubMed ID: 25248837
[TBL] [Abstract][Full Text] [Related]
15. Nicotine and caffeine-mediated modulation in the expression of toxicant responsive genes and vesicular monoamine transporter-2 in 1-methyl 4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease phenotype in mouse.
Singh S; Singh K; Patel S; Patel DK; Singh C; Nath C; Singh MP
Brain Res; 2008 May; 1207():193-206. PubMed ID: 18374908
[TBL] [Abstract][Full Text] [Related]
16. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity.
Nwanze E; Souverbie F; Jonsson G; Sundström E
Neurotoxicology; 1995; 16(3):469-77. PubMed ID: 8584278
[TBL] [Abstract][Full Text] [Related]
17. Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability.
Yang MC; McLean AJ; Le Couteur DG
Biochem Biophys Res Commun; 2001 Nov; 289(1):130-6. PubMed ID: 11708789
[TBL] [Abstract][Full Text] [Related]
18. Tobacco smoke chemicals attenuate brain-to-blood potassium transport mediated by the Na,K,2Cl-cotransporter during hypoxia-reoxygenation.
Paulson JR; Roder KE; McAfee G; Allen DD; Van der Schyf CJ; Abbruscato TJ
J Pharmacol Exp Ther; 2006 Jan; 316(1):248-54. PubMed ID: 16174793
[TBL] [Abstract][Full Text] [Related]
19. Copper reduces striatal protein nitration and tyrosine hydroxylase inactivation induced by MPP+ in rats.
Rubio-Osornio M; Montes S; Pérez-Severiano F; Aguilera P; Floriano-Sánchez E; Monroy-Noyola A; Rubio C; Ríos C
Neurochem Int; 2009 Jun; 54(7):447-51. PubMed ID: 19428787
[TBL] [Abstract][Full Text] [Related]
20. Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes.
Inazu M; Takeda H; Matsumiya T
J Neurochem; 2005 Sep; 94(5):1427-37. PubMed ID: 16000150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
